Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Rheumatoid Arthritis

Free Subscription 16.03.2026 4 Ann Rheum Dis 2 Clin Exp Rheumatol 8 Clin Rheumatol 1 Immunology 1 J Immunol 1 J Rheumatol 2 PLoS One 1 Proc Natl Acad Sci U S A 2 Rheumatol Int

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. NAGAFUCHI Y, Maarseveen TD, Lend K, Rudin A, et al
   Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
   Ann Rheum Dis. 2026 Mar 7:S0003-4967(26)00080-4. doi: 10.1016/j.ard.2026.
   PubMed         Abstract available
   
   
2. WANG H, Nugteren S, Groenland R, van der Meulen S, et al
   Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'.
   Ann Rheum Dis. 2025 Dec 18:S0003-4967(25)04546-7. doi: 10.1016/j.ard.2025.
   PubMed        
   
   
3. TON DA, van der Helm-van Mil AHM
   Tenosynovium, the likely first inflamed joint tissue during the development of arthritis in emerging rheumatoid arthritis.
   Ann Rheum Dis. 2026 Mar 1:S0003-4967(26)00087-7. doi: 10.1016/j.ard.2026.
   PubMed        
   
   
4. IMAI Y, Kono M, Ishii T, Kojima T, et al
   Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial).
   Ann Rheum Dis. 2026 Feb 27:S0003-4967(26)00079-8. doi: 10.1016/j.ard.2026.
   PubMed         Abstract available
   
   

   
   Clin Exp Rheumatol

5. COUDERC M, Soubrier M
   Ocrelizumab in a difficult-to-treat rheumatoid arthritis patient.
   Clin Exp Rheumatol. 2026 Mar 6. doi: 10.55563.
   PubMed        
   
   
6. CUI J, Yu Z, Oakes EG, Truong B, et al
   Clonal haematopoiesis and risk of incident rheumatoid arthritis: results from the UK biobank.
   Clin Exp Rheumatol. 2026 Mar 4:10.55563.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

7. ZHANG Y, Duo R, Li Z, Liu Y, et al
   NEDD4L knockdown enhances synovial fibroblast migration, invasion, and inflammatory factor secretion via Wnt/beta-Catenin signaling activation.
   Clin Rheumatol. 2026;45:2385-2399.
   PubMed         Abstract available
   
   
8. DONG K, Li M, Ye H, Xu Z, et al
   Elevated serum MMP3 levels as a potential biomarker of disease activity in primary Sjogren's syndrome: a prospective observational study.
   Clin Rheumatol. 2026;45:2287-2295.
   PubMed         Abstract available
   
   
9. OGUN H, Terlemez R, Palamar D, Akgun K, et al
   Evaluation of crystal-related arthritis in patients with knee effusion: insights from ultrasonography, microscopy and radiography.
   Clin Rheumatol. 2026;45:2319-2327.
   PubMed         Abstract available
   
   
10. LI Y, Xu K, Liu G, Li W, et al
    Comparison of agreement between three classification criteria for early rheumatoid arthritis (ERA) in Shanxi Province of China.
    Clin Rheumatol. 2026 Feb 28. doi: 10.1007/s10067-026-07990.
    PubMed         Abstract available
    
    
11. SINGH P, Parab SB, Khan A, Doshi G, et al
    Protective effects of Syringic acid on joint inflammation and damage in a rat model of rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 6. doi: 10.1007/s10067-026-08020.
    PubMed         Abstract available
    
    
12. TAKAHASHI S, Takahashi M, Shinohara M, Saegusa J, et al
    Serum beta-hydroxybutyrate as a diagnostic biomarker distinguishing acute calcium pyrophosphate crystal arthritis from rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 7. doi: 10.1007/s10067-026-08016.
    PubMed         Abstract available
    
    
13. VEGA-MORALES D, Machado P, Bergstra SA, la Fuente WO, et al
    Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning study.
    Clin Rheumatol. 2026 Mar 9. doi: 10.1007/s10067-026-08013.
    PubMed         Abstract available
    
    
14. ZERIHUN TE, Bekalu AF, Kasaw AT, Mussie DA, et al
    Determinant of health-related quality of life among patients with rheumatoid arthritis in North West Ethiopia, 2025: a multicenter cross-sectional study.
    Clin Rheumatol. 2026 Mar 11. doi: 10.1007/s10067-026-07956.
    PubMed         Abstract available
    
    

    
    Immunology

15. XIONG Z, Gao Y, He J, Bahabayi A, et al
    GPR56 Outperforms CD319 as a Discriminative Marker for CD4 (+) Cytotoxic T Lymphocytes and Is Elevated in Primary Sjogren's Syndrome.
    Immunology. 2026;177:713-724.
    PubMed         Abstract available
    
    

    
    J Immunol

16. ZHANG Z, Bahabayi A, Gao Y, Liu D, et al
    T cells co-expressing high levels of CD29 and CD99 show increased cytotoxic potential and are upregulated in Sjogren's disease.
    J Immunol. 2026;215:vkaf370.
    PubMed         Abstract available
    
    

    
    J Rheumatol

17. CURTIS JR, Emery P, Kricorian G, Yen PK, et al
    Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023;50:1114-1120.
    PubMed         Abstract available
    
    

    
    PLoS One

18. TRAN HTT, Duong TM, Nguyen TV, Le HTT, et al
    Suicidal ideation and interrelated psychiatric disturbances in rheumatoid arthritis: Evidence from a Vietnamese cohort.
    PLoS One. 2026;21:e0342909.
    PubMed         Abstract available
    
    
19. CHI JH, Lee BJ
    Association of hand grip strength with rheumatoid arthritis and osteoarthritis in the Korean population: A large-scale cross-sectional study.
    PLoS One. 2026;21:e0343150.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

20. HE X, Gong L, Zhang J, Pang X, et al
    Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis.
    Proc Natl Acad Sci U S A. 2026;123:e2525897123.
    PubMed         Abstract available
    
    

    
    Rheumatol Int

21. BEKARYSSOVA D, Mruthyunjaya Vijaya P, Ahmed S, Sondur S, et al
    Revisiting articular syndrome in the peri-pandemic COVID-19 era.
    Rheumatol Int. 2023;43:2157-2166.
    PubMed         Abstract available
    
    
22. BHAT SS, Ahmed S, Reji R, Mehta P, et al
    Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
    Rheumatol Int. 2023;43:2193-2200.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum